Company initiatives, Investments, Press Release

Lanxess invests in enzymes

Enzymes technology developer evocatal GmbH has completed a Series B financing round with new investors NRW.BANK and LANXESS as well as existing investors also taking part on the recent financing. The investments from this round of financing will be used to extend the firm’s technology platform as well as its product portfolio.

FOLLOW ME ON THESE SPACE
0Shares

About Doris de Guzman

Doris de Guzman examines alternative processing, new technology, R&D and other sustainability initiatives aimed at preventing pollution and lowering carbon emissions through news aggregation, market data analysis and information collaboration.

Discussion

Comments are closed.

Archives

Meta